Research Output per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 24 Similar Profiles
Tuberculosis
Medicine & Life Sciences
rifapentine
Medicine & Life Sciences
Pyrazinamide
Medicine & Life Sciences
Rifampin
Medicine & Life Sciences
Mycobacterium tuberculosis
Medicine & Life Sciences
Linezolid
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Multidrug-Resistant Tuberculosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1999 2019
Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection
Kaushik, A., Ammerman, N., Tyagi, S., Saini, V., Vervoort, I., Lachau-Durand, S., Nuermberger, E. & Andries, K., Apr 1 2019, In : Antimicrobial agents and chemotherapy. e00007-19.Research output: Contribution to journal › Article
Open Access
bedaquiline
Latent Tuberculosis
Injections
rifapentine
Lung
Advancing translational science for pulmonary nontuberculous mycobacterial infections: A road map for research
Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E., Olivier, K. N., Ordway, D. J., Prevots, D. R., Sacchettini, J. C., Salfinger, M. & 4 others, Apr 15 2019, In : American journal of respiratory and critical care medicine. 199, 8, p. 947-951 5 p.Research output: Contribution to journal › Review article
Lung
Infection
Research
Contribution of pretomanid to novel regimens containing bedaquiline with either linezolid or moxifloxacin and pyrazinamide in murine models of tuberculosis
Xu, J., Li, S. Y., Almeida, D. V., Tasneen, R., Barnes-Boyle, K., Converse, P. J., Upton, A. M., Mdluli, K., Fotouhi, N. & Nuermberger, E., May 1 2019, In : Antimicrobial agents and chemotherapy. 63, 5, e00021-19.Research output: Contribution to journal › Article
Open Access
Linezolid
bedaquiline
Pyrazinamide
Tuberculosis
Nude Mice
High-dose rifamycins enable shorter oral treatment in a murine model of mycobacterium ulcerans disease
Omansen, T. F., Almeida, D., Converse, P. J., Li, S. Y., Lee, J., Stienstra, Y., van der Werf, T., Grosset, J. H. & Nuermberger, E., Feb 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 2, e01478-18.Research output: Contribution to journal › Article
rifapentine
Rifamycins
Mycobacterium ulcerans
Rifampin
Buruli Ulcer
In vitro activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of mycobacterium abscessus
Kaushik, A., Ammerman, N., Martins, O., Parrish, N. M. & Nuermberger, E., Jun 1 2019, In : Antimicrobial agents and chemotherapy. 63, 6, e00470-19.Research output: Contribution to journal › Article
Mycobacterium
Tetracycline
Pharmaceutical Preparations
Salvage Therapy
Mycobacterium Infections